Profile
Boxer Capital Management is a biotechnology investment firm based in San Diego, California. The firm is committed to research-based investing in specialized and precision medicine companies, both private and public. Boxer Capital is composed of a team of experienced scientists and investment professionals with nearly two decades of experience in life sciences and biotechnology sectors. Their approach is characterized by a combination of scientific expertise and investment acumen, allowing the firm to rigorously analyze and invest in promising medical advancements.
Boxer Capital targets investments across the drug life cycle, from early-stage innovation to late-stage development in biotechnology. They focus particularly on novel, transformative medical technologies with the potential to improve patient care significantly. The firm takes a disciplined, fundamental research approach to identify lucrative opportunities within the biotech ecosystem. They do not specify regular LPs or strategic partners, but their investments are global in scope.
Boxer Capital has been instrumental in the growth of several biotech companies, such as Pandion Therapeutics, Mirati Therapeutics, and Prometheus Biosciences. These companies represent a range of innovative medical treatments and novel drug targets that align with Boxer Capital's investment philosophy.
Industry
Boxer Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Boxer Capital
|
Private Equity (PE)
|
Biotechnology
Life Sciences
|
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$2500 M
|
February 2005
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.